These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35538539)

  • 1. The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation.
    Nguyen HO; Salvi V; Tiberio L; Facchinetti F; Govoni M; Villetti G; Civelli M; Barbazza I; Gaudenzi C; Passari M; Schioppa T; Sozio F; Del Prete A; Sozzani S; Bosisio D
    J Transl Med; 2022 May; 20(1):203. PubMed ID: 35538539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAs.
    Nguyen HO; Schioppa T; Tiberio L; Facchinetti F; Villetti G; Civelli M; Del Prete A; Sozio F; Gaudenzi C; Passari M; Barbazza I; Sozzani S; Salvi V; Bosisio D
    Front Immunol; 2021; 12():797390. PubMed ID: 35140709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Human Dendritic Cell Functions by Phosphodiesterase-4 Inhibitors: Potential Relevance for the Treatment of Respiratory Diseases.
    Nguyen HO; Tiberio L; Facchinetti F; Ripari G; Violi V; Villetti G; Salvi V; Bosisio D
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PDE4 Inhibitor Tanimilast Restrains the Tissue-Damaging Properties of Human Neutrophils.
    Schioppa T; Nguyen HO; Salvi V; Maugeri N; Facchinetti F; Villetti G; Civelli M; Gaudenzi C; Passari M; Sozio F; Barbazza I; Tamassia N; Cassatella MA; Del Prete A; Bosisio D; Tiberio L
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phosphodiesterase 4 inhibitor roflumilast augments the Th17-promoting capability of dendritic cells by enhancing IL-23 production, and impairs their T cell stimulatory activity due to elevated IL-10.
    Bros M; Montermann E; Cholaszczyńska A; Reske-Kunz AB
    Int Immunopharmacol; 2016 Jun; 35():174-184. PubMed ID: 27070502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen-enhanced thrombomodulin (blood dendritic cell antigen 3, CD141) expression on dendritic cells is associated with a TH2-skewed immune response.
    Yerkovich ST; Roponen M; Smith ME; McKenna K; Bosco A; Subrata LS; Mamessier E; Wikström ME; Le Souef P; Sly PD; Holt PG; Upham JW
    J Allergy Clin Immunol; 2009 Jan; 123(1):209-216.e4. PubMed ID: 18947863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease.
    Facchinetti F; Civelli M; Singh D; Papi A; Emirova A; Govoni M
    Front Pharmacol; 2021; 12():740803. PubMed ID: 34887752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol inhibits dysfunction of dendritic cells from chronic obstructive pulmonary disease patients through promoting miR-34.
    Wang X; Zhang C; Huang G; Han D; Guo Y; Meng X; Kan C
    Int J Clin Exp Pathol; 2015; 8(5):5145-52. PubMed ID: 26191210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IL-8 as a Determinant of Response to Phosphodiesterase-4 Inhibition in Chronic Obstructive Pulmonary Disease.
    Govoni M; Bassi M; Santoro D; Donegan S; Singh D
    Am J Respir Crit Care Med; 2023 Sep; 208(5):559-569. PubMed ID: 37192443
    [No Abstract]   [Full Text] [Related]  

  • 10. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
    Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
    Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PDE4 inhibitor CHF6001 modulates pro-inflammatory cytokines, chemokines and Th1- and Th17-polarizing cytokines in human dendritic cells.
    Gianello V; Salvi V; Parola C; Moretto N; Facchinetti F; Civelli M; Villetti G; Bosisio D; Sozzani S
    Biochem Pharmacol; 2019 May; 163():371-380. PubMed ID: 30851246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerogenic signaling by pulmonary CD1c+ dendritic cells induces regulatory T cells in patients with chronic obstructive pulmonary disease by IL-27/IL-10/inducible costimulator ligand.
    Tsoumakidou M; Tousa S; Semitekolou M; Panagiotou P; Panagiotou A; Morianos I; Litsiou E; Trochoutsou AI; Konstantinou M; Potaris K; Footitt J; Mallia P; Zakynthinos S; Johnston SL; Xanthou G
    J Allergy Clin Immunol; 2014 Oct; 134(4):944-954.e8. PubMed ID: 25051954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells.
    Oehrl S; Prakash H; Ebling A; Trenkler N; Wölbing P; Kunze A; Döbel T; Schmitz M; Enk A; Schäkel K
    J Dermatol Sci; 2017 Aug; 87(2):110-115. PubMed ID: 28499587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells matured in the presence of the lycopodium alkaloid annotine direct T cell responses toward a Th2/Treg phenotype.
    Hardardottir I; Olafsdottir ES; Freysdottir J
    Phytomedicine; 2015 Feb; 22(2):277-82. PubMed ID: 25765833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.
    Jongbloed SL; Kassianos AJ; McDonald KJ; Clark GJ; Ju X; Angel CE; Chen CJ; Dunbar PR; Wadley RB; Jeet V; Vulink AJ; Hart DN; Radford KJ
    J Exp Med; 2010 Jun; 207(6):1247-60. PubMed ID: 20479116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular glutathione redox status in human dendritic cells regulates IL-27 production and T-cell polarization.
    Kamide Y; Utsugi M; Dobashi K; Ono A; Ishizuka T; Hisada T; Koga Y; Uno K; Hamuro J; Mori M
    Allergy; 2011 Sep; 66(9):1183-92. PubMed ID: 21545428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of monomethylfumarate on dendritic cell differentiation.
    Litjens NH; Rademaker M; Ravensbergen B; Thio HB; van Dissel JT; Nibbering PH
    Br J Dermatol; 2006 Feb; 154(2):211-7. PubMed ID: 16433787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of β-catenin affect the immuno-phenotype and functions of dendritic cells in an inhibitor-specific manner.
    Käfer R; Usanova S; Montermann E; Loquai C; Reske-Kunz AB; Bros M
    Int Immunopharmacol; 2016 Mar; 32():118-124. PubMed ID: 26824774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells generated in the presence of vitamin D3 and stimulated with lipopolysaccharide secrete IL-8, IL-1β, IL-10 and induce relatively low levels of CD4+CD25hiFoxp3+ T cells.
    Muñoz SM; Rodríguez LS
    Biomedica; 2016 Jun; 36(2):239-50. PubMed ID: 27622485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.